Your browser doesn't support javascript.
loading
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison.
le Roux, Carel W; Hankosky, Emily R; Wang, Duzhe; Malik, Raleigh; Yu, Maria; Hickey, Ana; Kan, Hong; Bunck, Mathijs C; Stefanski, Adam; Garcia-Perez, Luis-Emilio; Wharton, Sean.
Afiliação
  • le Roux CW; Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
  • Hankosky ER; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Wang D; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Malik R; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Yu M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Hickey A; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Kan H; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Bunck MC; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Stefanski A; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Garcia-Perez LE; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Wharton S; McMaster University, York University and Wharton Weight Management Clinic, Toronto, Ontario, Canada.
Diabetes Obes Metab ; 25(9): 2626-2633, 2023 09.
Article em En | MEDLINE | ID: mdl-37344384
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemiantes Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemiantes Idioma: En Ano de publicação: 2023 Tipo de documento: Article